Start 30 days free, no card. Full Pro access for a month, then decide. Start free

Back to analysts list

Analyst

Kevin McCarthy

Vertical Research Partners · covers Basic Materials

Period: Reporting periods mapped to calendar 2024 Q3 – 2026 Q2 (8 quarters).

Questions
69on tracked calls
Challenge rate
4%3 of 69 questions
Companies
10questioned at least once
Reporting periods
8with questions

These figures cover the whole profile: every tracked question, all reporting periods.

How to read these numbers

Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.

Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.

No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.

Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.

Small samples. Profiles with fewer than 10 questions are marked Limited sample.

Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.

Questions asked

Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.

Showing 69 of 69 questions from 10 companies

APDAir Products12 questions · 8 reporting periods · 0 of 12 challenging
APD company page →

Calendar 2026 Q2

conceptually, should investors think of that deal as fully hedging

Capital AllocationPricingTranscript · FY2026 Q3 →
Show response

Eduardo framed the Yara agreement as eliminating volume/offtake risk while APD retains most of the price risk, with a commission structure that shares upside as Yara commercializes the green ammonia.

Can you elaborate on the source of incremental goodness in the earnings function in helium?

PricingSupply ChainTranscript · FY2026 Q3 →
Show response

Eduardo attributed helium improvement to new long-term agreements tied to electronics projects (mostly Asia, some U.S.) and supply reliability from the Texas cavern; Qatar volumes remain very limited so APD isn't counting on Middle East supply.

Calendar 2026 Q1

Can you speak to what you're baking into your financial guidance for volume growth in the back half of the year?

DemandGuidance ReliabilityTranscript · FY2026 Q2 →
Show response

Eduardo explained guidance raise reflects Q2 beat only, with second half assumptions unchanged due to significant uncertainty from Middle East conflict.

Can you speak to your degrees of freedom on the supply side of the helium market? I appreciate you have large inventory buffer

Supply ChainCompetitive DynamicsTranscript · FY2026 Q2 →
Show response

Eduardo described Kansas liquefaction capacity and Texas cavern as key flexibility. Can cover one source down but not more. 900-mile supply chain from East Texas to Kansas.

Calendar 2025 Q4

can you comment on the sequential price change for helium and whether or not your Asia price of negative 1 would have been flat or possibly positive

PricingSupply ChainTranscript · FY2026 Q1 →
Show response

Melissa confirmed Asia price would have been slightly positive ex-helium. Global helium price impact was -1%. Americas and Europe non-helium price was up more significantly.

can you comment on the expected timing of that event and the specific trigger

Capital AllocationCapex InvestmentTranscript · FY2026 Q1 →
Show response

Melissa confirmed deconsolidation upon JV operations mid-2027. Debt comes off full balance sheet into equity affiliate line. Operating costs will ramp up pre-onstream then reduce to 33% share post-deconsolidation.

Calendar 2025 Q3

Would you comment on the market for rare gases, like crypton, xenon, neon, are you seeing any escalation of competitive intensity in Asia?

Competitive DynamicsPricingTranscript · FY2025 Q4 →
Show response

Eduardo acknowledged some pricing degradation and increased competition in rare gases but noted APD is not a significant player in this market.

Can you elaborate on the decision to sell to coal gasification projects in Asia curious about what exactly you're divesting

Capital AllocationGeographic ExpansionTranscript · FY2025 Q4 →
Show response

Eduardo confirmed Lu'An performing well and retained. Two other gasification projects with customer payment issues set aside for sale. Impact on sales limited as only paid sales were being booked. Seeking better owner for assets.

Calendar 2025 Q2

when do you think we might turn the corner? And how might you rank order the most important drivers to get those returns higher

Capital AllocationMarginTranscript · FY2025 Q3 →
Show response

Melissa explained ROCE is depressed by construction-in-progress (NEOM consolidation). Ex-CIP and cash, ROCE would be 500bp higher. Decline as project backlog completes will improve metric.

Calendar 2025 Q1

I think Air Products is pursuing partnerships for sequestration and also, as I understood, financial partners with an eye toward project financing. So how are those discussions going?

Capex InvestmentCapital AllocationTranscript · FY2025 Q2 →
Show response

Eduardo emphasized capital cost certainty as the gating factor, not permits. Gave end-of-year timeline for partnership decisions.

Calendar 2024 Q4

I think Air Products has signaled in the past that you would intend to be free-cash flow positive in fiscal 2027, I believe. Is that still the case?

Capital AllocationCapex InvestmentTranscript · FY2025 Q1 →
Show response

Melissa confirmed FY2027 net cash flow positive target, noting potential for equity partnerships or project financing to further improve trajectory.

Calendar 2024 Q3

would it be contingent upon bringing in a partner and/or project financing in Louisiana, or could you get there on an organic basis

Capital AllocationCapex InvestmentTranscript · FY2024 Q4 →
Show response

Melissa confirmed 2027 net cash flow positive target assumes NO project financing or equity partnerships, purely from project on-stream timing.

CTVACorteva7 questions · 7 reporting periods · 0 of 7 challenging
CTVA company page →

Calendar 2026 Q2

In crop protection, organic sales were down about 6%. But, on a product line basis, it looks like the trend was lower

PricingDemandCompetitive DynamicsTranscript · FY2026 Q2 →
Show response

Chuck Magro framed a recovering market with volume growth and low single digit pricing down, but did not break out the product-line detail requested.

Calendar 2026 Q1

you might walk us through some of the next mileposts that you are most focused on in terms of the pending separation

M&ACapital AllocationTranscript · FY2026 Q1 →
Show response

Chuck outlined remaining milestones: HQ decisions in Q2, public Form 10 filing in Q2, board announcements in H2, capital structure finalization, and September 15 Investor Day.

Calendar 2025 Q4

do you expect that to happen in 2026? And what might it mean for Corteva over the medium to long term?

Regulation PolicyInnovation & R&DTranscript · FY2025 Q4 →
Show response

Chuck said EU framework agreed in December, expecting formal adoption by H1 2026. Still need China approval as last significant import market. Gene-edited fungal disease-resistant corn (disease super locus) looks fantastic in test fields, commercialization within 1-2 years of regulatory approval.

Calendar 2025 Q3

can you discuss how credit market conditions are evolving for growers in Latin America and what that means for Corteva

CreditGeographic ExpansionTranscript · FY2025 Q3 →
Show response

David acknowledged industry seeing higher borrowing costs and increased bankruptcies. Corteva managing well, past dues as % of AR improved 200bp YoY. About 40% of Brazil sales on barter system for risk mitigation.

Calendar 2025 Q2

I want to dive into fungicides, which was up 40%

Product LaunchRevenue GrowthTranscript · FY2025 Q2 →
Show response

Robert said fungicide growth driven by Onmira brand return to Brazil market at acceptable margins after 2023 price declines. FMC Forcivo partnership gives premium 3-way corn fungicide for North America.

Calendar 2025 Q1

talk a little bit about the ramp to the economic opportunity. Are you still on track for a 2027 launch in hybrid red winter wheat?

Innovation & R&DProduct LaunchTranscript · FY2025 Q1 →
Show response

Chuck confirmed on track for 2027 hybrid wheat launch with 10-20% yield unlock, $1B peak revenue potential. Winter canola pilot expanding from 30,000 to potentially hundreds of thousands of acres.

Calendar 2024 Q4

crop protection EBITDA margins increased 800 basis points year over year

MarginRevenue GrowthTranscript · FY2024 Q4 →
Show response

Robert attributed margin gains to biologicals, new products, spinosyns, favorable mix toward fungicides/insecticides, and $170M cost takeout in Q4.

DOWDow Inc.7 questions · 7 reporting periods · 0 of 7 challenging
DOW company page →

Calendar 2026 Q2

Can you talk about what you're baking into your guide for U.S. Gulf Coast operations in the third quarter

Supply ChainDemandTranscript · FY2026 Q2 →
Show response

Carter guided operating rates above 90% once the cracker turnaround completes and said the Thailand JV has adequate feedstock with improved margins.

Calendar 2026 Q1

Would love your thoughts on that subject in terms of physical damage to assets in the Middle East, new plants that we thought might be starting up that are in fact unable to do so

Supply ChainCompetitive DynamicsTranscript · FY2026 Q1 →
Show response

Fitterling said most attacks relatively limited and repairable within 275-day logistics window. Exception is Qatar LNG plant critical equipment requiring 2.5-3 years to rebuild. Partners actively working on repairs. Does not expect damage to extend beyond logistics constraint duration.

Calendar 2025 Q4

Can you talk about the variances that manifested in that segment versus your prior expectations?

DemandCompetitive DynamicsTranscript · FY2025 Q4 →
Show response

Carter attributed weakness to building/construction and durables pressure globally. Fitterling said polyurethanes review active: took out 20% NA PO capacity; China 13% duty drawback expiring April; antidumping cases gaining traction.

Calendar 2025 Q3

How are your October and November order book shaping up relative to normal seasonal patterns?

Show response

Fitterling said order books right down the middle, not too conservative or optimistic. Cited Harvard report: US GDP ex data centers at 0.1%. MDI diverted from US showing up in Europe being dumped.

Calendar 2025 Q2

do you think $700 million could be a durable trough for quarterly earnings

DemandMacroeconomicTranscript · FY2025 Q2 →
Show response

Fitterling confirmed peak timing flexing toward 2030, declined to call trough. Focus on investing at bottom of cycle to maximize upcycle. Noted China starting to acknowledge overcapacity.

Calendar 2025 Q1

can you elaborate on how and why, I guess, you've expanded your scope of strategic review there with emphasis on polyurethanes

Competitive DynamicsCost PressureTranscript · FY2025 Q1 →
Show response

Fitterling said polyurethanes had a better owner. European ethylene capacity headed toward 20% reduction which should rebalance. Idle vs shutdown depends on optionality value, cited Saint Charles cracker story.

Calendar 2024 Q4

I was wondering if you'd walk-through your view of non-operating sources of cash-flow and uses in 2025

Capital AllocationTranscript · FY2024 Q4 →
Show response

Fitterling provided comprehensive cash flow framework: ~70% conversion, CapEx $3-3.2B, dividend $2B, infrastructure $2.4-3B, net interest $600M. Nova progress expected during year.

LINLinde plc7 questions · 6 reporting periods · 0 of 7 challenging
LIN company page →

Calendar 2026 Q2

if I look at your volume trend in Asia, it was up 6 percent for a second consecutive quarter.

DemandGeographic ExpansionTranscript · FY2026 Q2 →
Show response

Sanjiv attributed the 6% Asia volume to three parts: positive base volume, sizeable electronics sale-of-equipment, and ASEAN project ramp-ups.

Calendar 2026 Q1

If I look at your Americas number of plus 2%, I think that's the best that you've posted since the third quarter of 2022

DemandMacroeconomicTranscript · FY2026 Q1 →
Show response

White said not yet a true global recovery, need all 3 regions running positively. Americas results and trends are positive. Global base volumes turned positive but not enough to round to 1%. Need to see EMEA catalyst.

how much incremental volume opportunity do you think may be available again, through long-term contracts that you're pursuing

Competitive DynamicsPricingTranscript · FY2026 Q1 →
Show response

White confirmed excess molecules available beyond current commitments but declined to quantify. Being selective on contract quality and customer commitment. Already signed a few new long-term deals.

Calendar 2025 Q4

would you comment on your U.S. Packaged gas business sales trends with regard to both gas and rent and hard goods

DemandMacroeconomicTranscript · FY2025 Q4 →
Show response

Sanjiv detailed three indicators: hard goods automation equipment up (investment for expected pickup), consumables flat to slightly down, gas similar. Automotive and large ag equipment customers remain cautious with hope for H2 improvement. Cautious optimism but no consumption pickup yet.

Calendar 2025 Q3

you commented in the prepared remarks with regard to electronics, that you expect robust growth for some time

DemandInnovation & R&DTranscript · FY2025 Q3 →
Show response

Sanjiv expects 9-11% semiconductor industry growth over 5 years to $1T. Logic steady, HBM/memory seeing significant pickup. Gas intensity continues increasing with advanced nodes. R&D engagement with OEMs confirms next-gen tools require even more gas.

Calendar 2025 Q2

what impact, if any, does the passage of the One Big Beautiful Bill Act have maybe internally for Linde?

Regulation PolicyCapex InvestmentTranscript · FY2025 Q2 →
Show response

Matt said minimal ETR impact but positive for cash taxes via reinstated bonus depreciation. IRRs on US projects could improve ~100bp. Enhanced 45Q supports blue hydrogen projects.

Calendar 2025 Q1

I'd be very interested to hear your updated thoughts on the near term, what you're seeing and hearing from your customers in April and May across end markets

MacroeconomicDemandTranscript · FY2025 Q1 →
Show response

Sanjiv gave detailed China view: steel weak, chemicals softer, but battery/EV and electronics growing. Medium-term growth moderated to low single digit IP. Smart plant AI reducing manning.

PPGPPG Industries7 questions · 7 reporting periods · 2 of 7 challenging
PPG company page →

Calendar 2026 Q2

So maybe you can kind of unpack the volume growth trajectory as you see it in that business?

Revenue GrowthCompetitive DynamicsTranscript · FY2026 Q2 →
Show response

Direct answer quantifying about $25 million of new business wins per quarter and explaining the packaging comp math.

Calendar 2026 Q1

I think you made a small acquisition recently in [ Ozark ] as part of [ Traffic Solutions ]. Curious about that deal

M&ACapital AllocationTranscript · FY2026 Q1 →
Show response

Knavish described Ozark as opportunistic, highly synergistic bolt-on at about $100M revenue, purchased at good price relative to prior sale. Raises traffic solutions margin profile. Traffic solutions valued as stable cash generator funding aerospace investments. Broader M&A: PPG has always had balance sheet capacity; discipline continues. Must be right asset (adds organic growth/margin), right time, right price. Two small bolt-ons this year plus an Allied Products productivity acquisition. M&A still not tip of the spear.

Calendar 2025 Q4

If I look at the EBITDA line, though, it was relatively flat. And so I was wondering if you could walk us through your thoughts on operating leverage

Show response

Knavish attributed weak leverage to refinish destocking (double-digit Q3, high-single Q4 declines). Higher-margin business declining overwhelms other gains. Expects flip in H2 2026 when distributor buying patterns normalize. Morales clarified segment earnings actually grew ~$20M YoY in Q4.

Calendar 2025 Q3

your sales actually grew year-over-year, notwithstanding the refinish pressure that you articulated. And yet the operating income declined on a year-over-year basis

Show response

Knavish attributed OI decline to two factors: refinish mix (above-segment-average margins going negative) and above-normal growth spending in aerospace and PMC. Confident short-term margin hit delivers long-term shareholder value.

Calendar 2025 Q2

I think share gains are a meaningful part of that. So I was wondering if you could talk through the Performance segment and maybe help us conceptualize the gains

Competitive DynamicsRevenue GrowthTranscript · FY2025 Q2 →
Show response

Knavish broke down $100M: most is auto OEM, then industrial coatings, then packaging. Packaging had known U.S. share loss offset by Europe gains and BPA NI technology wins. PMC driven by new technologies (SigmaGlide, Sale Advance, fire protection). Morales noted all 4 Performance businesses outgrew markets in Q2.

Calendar 2025 Q1

I was wondering if you could unpack the sales guidance that you've provided on Slide 11 for global architectural coatings in particular

DemandRevenue GrowthTranscript · FY2025 Q1 →
Show response

Knavish declined to predict FX but confirmed incrementally positive pricing expected. Mexico project pause likely continues into Q2. Europe is the key change driver Q1 to Q2, momentum growing, could be flat to incrementally positive.

Calendar 2024 Q4

how do you expect volume to trend through the balance of the year? And how much of the implied improvement in the progression relates to potential macro uplift

DemandRevenue GrowthTranscript · FY2024 Q4 →
Show response

Knavish outlined negative Q1 volumes ramping to positive low-single-digits for full year. Emphasized stabilization rather than hockey-stick recovery, with $100M industrial share gains providing visibility.

SHWThe Sherwin-Williams Company7 questions · 7 reporting periods · 0 of 7 challenging
SHW company page →

Calendar 2026 Q2

are there certain businesses where you have been pleasantly surprised by the magnitude of share gains

Competitive DynamicsDemandTranscript · FY2026 Q2 →
Show response

Petz named commercial as the standout and new residential plus industrial wood as the hardest, restating the 1.5x to 2x market growth expectation.

Calendar 2026 Q1

have you implemented incremental pricing since the onset of the war on March 1

PricingCost PressureTranscript · FY2026 Q1 →
Show response

Ben clarified consolidated pricing includes both January stores increase and new incremental actions especially in Performance Coatings Group. On raws, expects heavier inflation in second half with exit rate at high end of low to mid single digits.

Calendar 2025 Q4

regarding the 7% price increase that you'd expect realization to be in the low single-digit percentage range.

PricingCompetitive DynamicsTranscript · FY2025 Q4 →
Show response

Heidi said realization would be at the low end of the historic range as a full-year guide given the unique competitive environment.

Calendar 2025 Q3

Do you have any price increases on the table that you care to call out for consumer brands or across the Performance Coatings Group.

Show response

Al confirmed targeted price increases across Consumer Brands and Performance Coatings segments and regions to offset cost basket pressures.

Calendar 2025 Q2

you doubled the size of your previously announced restructuring program. Wondering if you could elaborate on the magnitude and flow through and sources of the savings

Cost PressureMarginTranscript · FY2025 Q2 →
Show response

Al said 20% of $105M restructuring is in gross profit (plant consolidations), majority is SG&A; expects ~$80M annual savings with good portion in H2 and rest annualizing into 2026.

Calendar 2025 Q1

one of the things that changed relative to last quarter is you announced in February an agreement to acquire BASF's architectural business in Brazil. In that context, I was wondering if you could t...

M&AGeographic ExpansionTranscript · FY2025 Q1 →
Show response

Heidi said Suvinil is an obvious complement to existing LatAm business; targeting H2 close; not yet in guidance. Jim added Brazil architectural grows faster than GDP and Suvinil faster still.

Calendar 2024 Q4

you mentioned in your prepared remarks you're pursuing increases in consumer and performance coatings

Show response

Heidi said Consumer and PCG pricing is targeted by region/geography without announcing specifics. Al sized FX drag as ~1% consolidated, mid-teens hit in Latin America translating to mid-single-digit Consumer impact and ~2% PCG impact.

Show 4 more companies
ALBAlbemarle Corporation6 questions · 4 reporting periods · 0 of 6 challenging
ALB company page →

Calendar 2026 Q2

Can you provide an update on where your own inventories are on a unit basis

InventorySupply ChainTranscript · FY2026 Q2 →
Show response

Neal said inventories ended historically low (working capital 19% of sales versus a normal 25%) after strong demand and the CGP3 fire, and will need rebuilding.

Calendar 2026 Q1

does Albemarle have any visibility at all into whether your lithium molecules end up in an EV versus an energy storage system?

Show response

Masters said visibility is good but not perfect since the same customers serve both markets. Understanding end-market destination matters for planning capacities and market approaches. Norris added carbonate for LFP could go either way but on-the-ground knowledge helps discern.

I was wondering if you could speak to the quarterly cadence of your lithium sales volumes

DemandRevenue GrowthTranscript · FY2026 Q1 →
Show response

Sheorey said Q1 is seasonally softest, Q2 and Q3 pick up, Q4 will not match prior year's strength due to inventory reductions in Q4 2025. Year-over-year comps get tougher through the year.

Calendar 2025 Q4

I would welcome your latest thoughts on potential to acquire lithium capacity versus build it

M&ACapital AllocationTranscript · FY2025 Q4 →
Show response

Masters said the focus is not on acquisitions at this point in the cycle. Organic growth opportunities at existing resources (La Negra, Chinese conversion facilities, tolling) are lower capital than greenfield. Would consider acquisitions at the right fit and price but not the current priority.

Calendar 2024 Q4

Can you comment on your outlook for 2025 in that end market? And is your share in grid storage higher or lower or about the same

DemandCompetitive DynamicsTranscript · FY2024 Q4 →
Show response

Masters highlighted grid storage as a bright spot with continued growth expectations. Norris noted market share mirrors their LFP EV share since the same customers are involved.

as the tariff regimes continue to evolve here. Are you managing the company any differently today than you were last year

Show response

Masters said direct tariff impact is minimal since Albemarle does not ship significantly from China to the U.S., but watching knock-on effects on customers.

ECLEcolab6 questions · 6 reporting periods · 0 of 6 challenging
ECL company page →

Calendar 2026 Q2

Is there a way to characterize or quantify the visibility that CoolIT has or you now have into the order backlog

Revenue GrowthM&AGuidance ReliabilityTranscript · FY2026 Q2 →
Show response

Beck gave visibility only through the end of 2026 and described a go-to-market split between chip designers and hyperscalers, deferring backlog metrics to the November session.

Calendar 2026 Q1

It looks like you were able to decrease your ratio of SG&A to sales by 130 basis points in the March quarter

MarginCost PressureTranscript · FY2026 Q1 →
Show response

Kirkland noted 20-30bps of the 130bps improvement was Ovivo geography between GM and SG&A. Underlying still above 25-50bps long-term target. Full year SG&A leverage expected around 100bps.

Calendar 2025 Q4

Is that to do with the aforementioned normalization or stabilization in basic industries? Or are you expecting your higher growth platforms to accelerate as well?

Revenue GrowthGuidance ReliabilityTranscript · FY2025 Q4 →
Show response

Beck confirmed acceleration driven by both normalization of Paper/Basic Industries and continued momentum in growth engines growing double-digit. GHT growing strong double-digit with specific numbers to be published in Q1. Cooling-as-a-service getting great customer reception.

Calendar 2025 Q2

is it purely cyclical? Or do you see any structural elements that may argue for pulling some levers?

DemandCompetitive DynamicsTranscript · FY2025 Q2 →
Show response

Beck confirmed no structural issues in basic industries. Power business has big future from AI/data center energy demand. Paper shifting from graphics to consumer products and specialized packaging. Neither business is a candidate for strategic exits.

Calendar 2025 Q1

I'm curious Christophe as to whether or not your thoughts on capital deployment have changed at all, with the external environment being so volatile

Capital AllocationM&ATranscript · FY2025 Q1 →
Show response

Beck confirmed no change to capital allocation. Net leverage 1.8x below 2x target. $140M share repurchases in Q1. M&A pipeline robust. Playing offense.

Calendar 2024 Q4

The relative margin differential between your US businesses and your international businesses and whether that's stable or narrowing or widening

Show response

Beck noted US above company average, international below but narrowing. All 11 global markets targeting 20% OI. FX drag 3%/4% is geographic mix.

LYBLyondellBasell6 questions · 6 reporting periods · 0 of 6 challenging
LYB company page →

Calendar 2026 Q2

Welcome any comments that you have on other pieces of the portfolio, whether it's the propylene chain

Supply ChainCompetitive DynamicsTranscript · FY2026 Q2 →
Show response

Foley cited Middle East LPG-to-Asia flows, with North and Southeast Asia ex-China running about 50%, partly offset by U.S. LPG exports narrowing the gap.

Calendar 2026 Q1

that business earned quarterly EBITDA between $1.5 billion and $1.6 billion at the last peak in the middle quarters of 2021

Show response

Peter noted PE pricing only $0.10-$0.15/lb below 2021 peak with further price increases expected. Margins also improving as ethane costs are lower than end of 2025. Kim confirmed CMA forecast agrees mid-cycle PE margins will be reached in Q2, similar to 2021 conditions. Noted PP upside is different, $0.60 higher price in 2021 means PP may not run up as fast but spreads will continue increasing.

Calendar 2025 Q4

I'd appreciate your updated thoughts on the U.S. Gulf Coast market for polyethylene

Show response

Kim walked through multiple supporting factors: ACC data shows industry inventories fell from 44 days post-liberation to ~40 in November, likely lower in December. Higher Q4 ethane/nat gas hurt Q4 profitability. Winter Storm Fern took derivative capacity offline. Export pricing rising in January. Downstream converters announcing price increases. Peter confirmed multiple indicators supporting announced price increases with integrated margins expected to improve.

Calendar 2025 Q2

can you talk through the third quarter dynamics that you see in the Intermediates and Derivatives segment

MarginSupply ChainTranscript · FY2025 Q2 →
Show response

Aaron explained Q1-to-Q2 step-up included one-time PO 11 JV exit costs in Q1. No material Q3 improvement expected across I&D. PO/derivative customers quoting 10%+ YoY declines. La Porte acetyls turnaround starts mid-September spanning Q3/Q4. Channelview methanol unit returning from unplanned outage will partially offset. Oxyfuels oversupplied in USGC with additional PO/TBA volume and Chinese exports displacing USGC.

Calendar 2025 Q1

I'm curious as to whether your forecast of things like demand growth and price premium levels have evolved at all

Innovation & R&DDemandTranscript · FY2025 Q1 →
Show response

Peter confirmed circular volumes grew double-digit in Q1. Historically 57% per year growth over 3 years. Brand owners reduced aspirations due to supply constraints, not demand loss. MoReTec-2 FID expected in 2026, seeking brand owner commitments first.

Calendar 2024 Q4

I'd appreciate your updated cycle view on the propylene chain or polypropylene

Competitive DynamicsSupply ChainTranscript · FY2024 Q4 →
Show response

Kim explained shift to lighter feedstocks reducing propylene supply, PDH units in China setting the floor. LYB investing in Flex 2 metathesis unit to secure propylene. Peter added NATPET JV expansion for low-cost PP and European capacity actions.

IFFInternational Flavors & Fragrances4 questions · 4 reporting periods · 1 of 4 challenging
IFF company page →

Calendar 2026 Q2

I was wondering if you could elaborate on what impact the separation will have on your CapEx.

Capex InvestmentMarginTranscript · FY2026 Q2 →
Show response

DeVeau said Remainco CapEx should run about 5% to 6% of sales (near the upper end near-term for high-return initiatives), with gross margin around 43%, EBITDA in the low 20s and SG&A 17-18%, improving as stranded costs come out.

Calendar 2025 Q4

finished on a somewhat stronger note. Can you elaborate on what drove the margin uplift there of 160 basis points year over year as the

Show response

Erik attributed H&B Q4 strength to volume growth and productivity. Health business showed less decline than Q3, expected to flatten in H1 2026 and return to growth in H2 2026 with full recovery in 2027.

Calendar 2025 Q2

you delivered some earnings upside in the first half, yet left the annual range is unchanged and now expect some growth to maybe moderate in the back half. So just wondering if you could parse that...

ChallengingRevenue GrowthDemandTranscript · FY2025 Q2 →
Show response

Erik pushed back on conservatism, citing two real challenges: health segment weakness (market plus internal commercial gaps) and fragrance ingredients commodity decline. Both expected to drag below market in H2 before recovering in 2026-2027.

Calendar 2025 Q1

Can you just elaborate on strategic rationale there, long-term opportunity, structure of the venture and timing of that cash investment

Innovation & R&DCapex InvestmentTranscript · FY2025 Q1 →
Show response

Erik detailed the 50/50 JV: EUR130M plant in Finland, split 50/50, startup by end of 2027. Kemira targets water treatment and packaging; IFF targets industrial applications.

Challenge rate by company

Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.

CompanyQuestionsChallenge rate
APD Air Products120%none of 12 questions
CTVA Corteva70%none of 7 questions
DOW Dow Inc.70%none of 7 questions
LIN Linde plc70%none of 7 questions
PPG PPG Industries729%2 of 7 questions
SHW The Sherwin-Williams Company70%none of 7 questions
ALB Albemarle Corporation60%none of 6 questions
ECL Ecolab60%none of 6 questions
LYB LyondellBasell60%none of 6 questions
IFF International Flavors & Fragrances425%1 of 4 questions
  • APD
    Air Products · 12 questions
    0%none of 12 questions
  • CTVA
    Corteva · 7 questions
    0%none of 7 questions
  • DOW
    Dow Inc. · 7 questions
    0%none of 7 questions
  • LIN
    Linde plc · 7 questions
    0%none of 7 questions
  • PPG
    PPG Industries · 7 questions
    29%2 of 7 questions
  • SHW
    The Sherwin-Williams Company · 7 questions
    0%none of 7 questions
  • ALB
    Albemarle Corporation · 6 questions
    0%none of 6 questions
  • ECL
    Ecolab · 6 questions
    0%none of 6 questions
  • LYB
    LyondellBasell · 6 questions
    0%none of 6 questions
  • IFF
    International Flavors & Fragrances · 4 questions
    25%1 of 4 questions

Activity by reporting period

Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.

Questions by calendar reporting period
Calendar periodQuestionsChallenge rateCompanies
2024 Q310%none of 1 question1
2024 Q490%none of 9 questions8
2025 Q190%none of 9 questions9
2025 Q2911%1 of 9 questions9
2025 Q3714%1 of 7 questions6
2025 Q4119%1 of 11 questions10
2026 Q1120%none of 12 questions9
2026 Q2110%none of 11 questions10
  1. 2024 Q31 question · challenge rate 0% (none of 1 question) · 1 company
  2. 2024 Q49 questions · challenge rate 0% (none of 9 questions) · 8 companies
  3. 2025 Q19 questions · challenge rate 0% (none of 9 questions) · 9 companies
  4. 2025 Q29 questions · challenge rate 11% (1 of 9 questions) · 9 companies
  5. 2025 Q37 questions · challenge rate 14% (1 of 7 questions) · 6 companies
  6. 2025 Q411 questions · challenge rate 9% (1 of 11 questions) · 10 companies
  7. 2026 Q112 questions · challenge rate 0% (none of 12 questions) · 9 companies
  8. 2026 Q211 questions · challenge rate 0% (none of 11 questions) · 10 companies

Topics

Topics tagged on this analyst’s questions.

  • Demand21
  • Competitive Dynamics15
  • Margin13
  • Capital Allocation12
  • Pricing12
  • Revenue Growth10
  • Supply Chain9
  • Capex Investment7
  • M&A6
  • Innovation & R&D5
Show all 20 topics
  • Geographic Expansion4
  • Cost Pressure4
  • Macroeconomic4
  • Guidance Reliability3
  • Regulation Policy2
  • Product Launch2
  • Fx2
  • Inventory1
  • Credit1
  • Trade Tariffs1